Crossmark

New generation agents for glycemic control and diabetic retinopathy progression: what we need to know?

Crossref DOI link: https://doi.org/10.1007/s00592-025-02552-w

Published Online: 2025-06-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vujosevic, Stela https://orcid.org/0000-0001-6773-9967
Toma, Caterina https://orcid.org/0000-0002-1505-6029
Ferrulli, Anna https://orcid.org/0000-0002-8518-5547
De Cillà, Stefano https://orcid.org/0000-0002-0267-3650
Nucci, Paolo https://orcid.org/0000-0002-4036-703X
Luzi, Livio https://orcid.org/0000-0003-3183-0552
License Information

Text and Data Mining valid from 2025-06-30

Version of Record valid from 2025-06-30
More Information

Article History

Received: 25 February 2025

Accepted: 9 June 2025

First Online: 30 June 2025

Declarations

:

: The Authors have no conflicts of interest to declare.